Studsvik (SVIK) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
8 Jul, 2026Executive summary
Achieved strong cash flow and improved profitability in 2025, driven by Fuel, Materials & Waste Technology segment performance and supported by new long-term contracts and investments.
No dividend proposed for 2025 to support a pro-growth capital allocation strategy and future investments.
Major new contracts secured with RoPower Nuclear (Romania) and KEPCO Nuclear Fuel (Korea), and acquisition of BlackStarTech in the USA to strengthen software offerings.
New large shareholder Segra Capital acquired close to 10% of shares, and new board members were appointed.
Strategic focus on innovation, acquisitions, and global customer expansion, including U.S. market and SMR/AMR business.
Financial highlights
Q4 net sales: SEK 222.9 million, down 4.4% year-over-year; full-year sales: SEK 883.3 million, up 1.1% in local currency.
Q4 operating profit: SEK 18.4 million (8.2% margin), up from SEK 1.6 million (0.7%) last year.
Full-year operating profit: SEK 68.6 million (7.8% margin), up from SEK 26.8 million (3%).
Free cash flow for 2025: SEK 98.3 million, a significant improvement from -SEK 78.1 million in 2024.
Net debt reduced to SEK 65.1 million after SEK 23.5 million in bank debt amortization.
Outlook and guidance
No dividend proposed for 2025 to support a pro-growth agenda and expansion in SMR/AMR markets.
Continued growth expected in Fuel, Materials & Waste Technology, supported by a robust backlog and customer engagement.
Decommissioning & Radiation Protection Services expected to improve profitability through 2026 after restructuring.
Strategic focus on expanding US market presence, enhancing hot cell capabilities, and increasing SMR/AMR business.
Vision for 2035 includes SMR, isotope center, and fusion test facility.
Latest events from Studsvik
- Q2 2026 sales rose 9.2% to SEK 247M, with strong investments and new build nuclear milestones.SVIK
Q2 202617 Jul 2026 - Sales up 4.1% y/y, profit and cash flow down, SMR acquisition boosts future prospects.SVIK
Q1 202623 Apr 2026 - Q1 2025 saw strong sales, margin gains, and cash flow, driven by nuclear demand and acquisitions.SVIK
Q1 20257 Apr 2026 - Q2 2024 sales and profit rose, with investments and partnerships driving future growth.SVIK
Q2 20243 Feb 2026 - Q3 profit fell sharply on US fraud and technical disruptions despite higher sales.SVIK
Q3 202419 Jan 2026 - Expanding nuclear lifecycle solutions, financial growth, and strategic focus on SMRs and US market.SVIK
ABGSC Investor Days9 Dec 2025 - Q4 sales rose 7.9%, with efficiency gains and acquisitions positioning for 2025 growth.SVIK
Q4 20242 Dec 2025 - Strong Q2 profit and margin growth driven by FMWT and SMR market opportunities.SVIK
Q2 202516 Nov 2025 - Q3 2025 delivered higher profits, strong cash flow, and strategic growth in a robust nuclear market.SVIK
Q3 20254 Nov 2025